Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.150
-0.110 (-4.87%)
Nov 12, 2024, 4:00 PM EST - Market closed

Tharimmune Statistics

Total Valuation

Tharimmune has a market cap or net worth of $2.47 million. The enterprise value is -$2.30 million.

Market Cap 2.47M
Enterprise Value -2.30M

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

Tharimmune has 1.15 million shares outstanding. The number of shares has increased by 2,357.50% in one year.

Current Share Class 1.15M
Shares Outstanding 1.15M
Shares Change (YoY) +2,357.50%
Shares Change (QoQ) +60.82%
Owned by Insiders (%) 1.66%
Owned by Institutions (%) 2.92%
Float 1.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.06
P/TBV Ratio 0.82
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.35

Current Ratio 2.35
Quick Ratio 2.14
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -837.16

Financial Efficiency

Return on equity (ROE) is -454.53% and return on invested capital (ROIC) is -291.07%.

Return on Equity (ROE) -454.53%
Return on Assets (ROA) -165.08%
Return on Capital (ROIC) -291.07%
Revenue Per Employee n/a
Profits Per Employee -$3.62M
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -96.95% in the last 52 weeks. The beta is 1.44, so Tharimmune's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change -96.95%
50-Day Moving Average 2.49
200-Day Moving Average 4.20
Relative Strength Index (RSI) 44.23
Average Volume (20 Days) 3,195,466

Short Selling Information

The latest short interest is 496,869, so 43.25% of the outstanding shares have been sold short.

Short Interest 496,869
Short Previous Month 17,697
Short % of Shares Out 43.25%
Short % of Float 43.98%
Short Ratio (days to cover) 0.37

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.12M
Pretax Income -8.88M
Net Income -10.85M
EBITDA n/a
EBIT -11.12M
Earnings Per Share (EPS) -$11.95
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 4.77M
Total Debt n/a
Net Cash 4.77M
Net Cash Per Share $4.16
Equity (Book Value) 3.02M
Book Value Per Share 2.03
Working Capital 3.02M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.28M
Capital Expenditures n/a
Free Cash Flow -9.28M
FCF Per Share -$8.08
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Tharimmune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,357.50%
Shareholder Yield -2,357.50%
Earnings Yield -439.33%
FCF Yield -375.89%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date May 28, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2